Detalhe da pesquisa
1.
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
Hepatology;
2024 Mar 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38470216
2.
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
Blood;
141(19): 2359-2371, 2023 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36626250
3.
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification.
Haematologica;
109(1): 231-244, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37439377
4.
Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
Blood;
138(18): 1721-1726, 2021 11 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34115836
5.
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity.
Blood;
138(18): 1705-1720, 2021 11 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34077955
6.
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.
Blood;
138(21): 2093-2105, 2021 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34125889
7.
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins.
Haematologica;
108(1): 219-233, 2023 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36073514
8.
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
Ann Hematol;
102(6): 1409-1420, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37079068
9.
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
Int J Mol Sci;
24(19)2023 Sep 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37834003
10.
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
Haematologica;
107(4): 921-932, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33951891
11.
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
Hematol Oncol;
40(5): 987-998, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35794705
12.
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.
Int J Mol Sci;
23(24)2022 Dec 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36555330
13.
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).
Haematologica;
106(11): 2918-2926, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33054126
14.
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.
Haematologica;
106(11): 2799-2812, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34261295
15.
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood;
132(6): 587-597, 2018 08 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29884741
16.
Genomic Classification and Prognosis in Acute Myeloid Leukemia.
N Engl J Med;
374(23): 2209-2221, 2016 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27276561
17.
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma.
Haematologica;
109(6): 1966-1972, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38385303
18.
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.
Hematol Oncol;
42(3): e3277, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38682493
19.
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
Am J Hematol;
94(6): 628-634, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30829413
20.
Signatures of mutational processes in human cancer.
Nature;
500(7463): 415-21, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23945592